Authors: Slingluff, CL Yamshchikov, G Neese, P Galavotti, H Eastham, S Engelhard, VH Kittlesen, D Deacon, D Hibbitts, S Grosh, WW Petroni, G Cohen, R Wiernasz, C Patterson, JW Conway, BP Ross, WG

Citation: Cl. Slingluff et al., Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: Immunologic and clinical outcomes, CLIN CANC R, 7(10), 2001, pp. 3012-3024

Authors: Simmons, G Reeves, JD Hibbitts, S Stine, JT Gray, PW Proudfoot, AEI Clapham, PR

Citation: G. Simmons et al., Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands, IMMUNOL REV, 177, 2000, pp. 112-126

Authors: Clapham, PR Reeves, JD Simmons, G Dejucq, N Hibbitts, S McKnight, A

Citation: Pr. Clapham et al., HIV coreceptors, cell tropism and inhibition by chemokine receptor ligands, MOL MEMBR B, 16(1), 1999, pp. 49-55

Authors: Hibbitts, S Reeves, JD Simmons, G Gray, PW Epstein, LG Schols, D De Clercq, E Wells, TNC Proudfoot, AEI Clapham, PR

Citation: S. Hibbitts et al., Coreceptor ligand inhibition of fetal brain cell infection by HIV type 1, AIDS RES H, 15(11), 1999, pp. 989-1000

Authors: Reeves, JD Hibbitts, S Simmons, G McKnight, A Azevedo-Pereira, JM Moniz-Pereira, J Clapham, PR

Citation: Jd. Reeves et al., Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: Comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo, J VIROLOGY, 73(9), 1999, pp. 7795-7804